Omeros to Present at Rodman and Renshaw 13th Annual Healthcare Conference
SEATTLE, Sept. 6, 2011 /PRNewswire via COMTEX/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the Rodman and Renshaw 13th Annual Healthcare Conference taking place in New York City next week. The presentation is scheduled for Tuesday, September 13, 2011 at 2:00 p.m. Eastern Time.
The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at http://www.omeros.com/.
About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.
SOURCE Omeros Corporation